Identifying therapeutic pathways targeting medulloblastoma-immune cell interactions
确定针对髓母细胞瘤-免疫细胞相互作用的治疗途径
基本信息
- 批准号:10219682
- 负责人:
- 金额:$ 59.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-05-01 至 2026-04-30
- 项目状态:未结题
- 来源:
- 关键词:AddressBindingBloodBlood - brain barrier anatomyBlood CirculationBrainBrain NeoplasmsCD47 geneCell CommunicationCell Surface ProteinsCell surfaceCellsChildhood Brain NeoplasmChildhood Malignant Brain TumorClinicalClinical DataComputer AnalysisComputer ModelsDataDendritic CellsDisease modelEnvironmentGenesHumanImmuneImmune systemImmunofluorescence ImmunologicImmunologic MarkersImmunologic SurveillanceImmunomodulatorsImmunooncologyImmunosuppressionImmunotherapyInterventionLigandsLinkMajor Histocompatibility ComplexMalignant NeoplasmsMapsMethodsMicrogliaModelingMolecularMusNatural Killer CellsOutcomePathway interactionsPatientsPeriodicityPeripheralPropertyProteinsProteomicsRegulationRegulatory PathwayResearchSHH geneSamplingSampling StudiesShapesSignal TransductionSiteSolid NeoplasmStreamSurfaceSurface AntigensSystems BiologyT-LymphocyteTNF geneTP53 geneTestingTherapeuticTherapeutic InterventionTranslatingTumor SubtypeTumor-associated macrophagesTumor-infiltrating immune cellsUpdateVariantWorkbasecausal modelcell typeclinically relevantcytokineexperimental studygenetic regulatory proteinimaging modalityimmunoreactionimmunoregulationimprovedinnovationinsightmacrophagemedulloblastomamouse modelmulti-scale modelingmutantneoplastic cellnoveloutcome predictionphosphoproteomicsprotein expressionsingle-cell RNA sequencingtargeted treatmenttherapeutic candidatetherapeutic developmenttherapeutic evaluationtherapeutic targettranscriptomicstumortumor growthtumor-immune system interactions
项目摘要
SUMMARY
We propose developing a systems-biology approach to understand interactions between tumor and immune
cells and their clinical implications. Our work will focus on medulloblastoma, a malignant pediatric brain tumor
in which our team has extensive expertise. We and others have shown that medulloblastoma tumors are sites
of immune activity despite the blood-brain barrier. However, the clinical consequences of these immune cells
are unclear and there is little information that might guide development of therapeutics that modulate these
immune cells.
Our innovative strategy combines single-cell methods, including single-cell proteomics, with a sophisticated
computational analysis. In Aim 1, we map the landscape of tumor-immune interactions using sequencing and
imaging methods on human samples. Aim 2 builds a causal model of the molecular interactions that govern
interactions among cell types in medulloblastoma, determines the clinical correlates of these cells, and
identifies potential therapeutic targets. Aim 3 maps the tumor-immune environment in well-validated mouse
models of the disease, and builds computational models for mice parallel to those for humans. Hypotheses
from Aim 2 that are likely to translate well to the mouse models are then tested for their effects on tumor
growth and survival. The mouse results are used to update the computational models and refine the
therapeutic strategies. We expect that successful completion of this project will have a substantial impact on
medulloblastoma therapeutics. Further, the methods we develop will catalyze research of interactions between
immune cells and many other tumor types beyond medulloblastoma.
概括
我们建议开发一种系统生物学方法来了解肿瘤与免疫之间的相互作用
细胞及其临床意义。我们的工作将集中于髓母细胞瘤,这是一种恶性小儿脑肿瘤
我们的团队拥有广泛的专业知识。我们和其他人表明髓母细胞瘤是部位
尽管存在血脑屏障,但免疫活性。但是,这些免疫细胞的临床后果
尚不清楚,很少有信息可以指导调节这些治疗剂的开发
免疫细胞。
我们的创新策略结合了包括单细胞蛋白质组学在内的单细胞方法和精致
计算分析。在AIM 1中,我们使用测序和
人类样品的成像方法。 AIM 2建立了控制分子相互作用的因果模型
髓母细胞瘤中细胞类型之间的相互作用,确定这些细胞的临床相关性,并确定
确定潜在的治疗靶标。 AIM 3映射验证的鼠标中的肿瘤免疫环境
该疾病的模型,并为小鼠与人类平行的小鼠建立计算模型。假设
然后从AIM 2转换为鼠标模型,然后测试其对肿瘤的影响
生长和生存。鼠标结果用于更新计算模型并完善
治疗策略。我们预计该项目的成功完成将对
髓母细胞瘤疗法。此外,我们开发的方法将催化对相互作用的研究
免疫细胞和许多其他肿瘤类型以外的髓母细胞瘤。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ernest Fraenkel其他文献
Ernest Fraenkel的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ernest Fraenkel', 18)}}的其他基金
The effects of Alzheimer's disease risk genes on metabolism and signaling across cell types
阿尔茨海默病风险基因对跨细胞类型代谢和信号传导的影响
- 批准号:
10524301 - 财政年份:2022
- 资助金额:
$ 59.4万 - 项目类别:
Identifying therapeutic pathways targeting medulloblastoma-immune cell interactions
确定针对髓母细胞瘤-免疫细胞相互作用的治疗途径
- 批准号:
10400097 - 财政年份:2021
- 资助金额:
$ 59.4万 - 项目类别:
Identifying therapeutic pathways targeting medulloblastoma-immune cell interactions
确定针对髓母细胞瘤-免疫细胞相互作用的治疗途径
- 批准号:
10615653 - 财政年份:2021
- 资助金额:
$ 59.4万 - 项目类别:
Epigenetic pathology and therapy in Huntington's disease
亨廷顿病的表观遗传学病理学和治疗
- 批准号:
10223442 - 财政年份:2015
- 资助金额:
$ 59.4万 - 项目类别:
Epigenetic pathology and therapy in Huntington's disease
亨廷顿病的表观遗传学病理学和治疗
- 批准号:
9988602 - 财政年份:2015
- 资助金额:
$ 59.4万 - 项目类别:
Epigenetic pathology and therapy in Huntington's disease
亨廷顿病的表观遗传学病理学和治疗
- 批准号:
10411989 - 财政年份:2015
- 资助金额:
$ 59.4万 - 项目类别:
Epigenetic Pathology and Therapy in Huntington's Disease
亨廷顿病的表观遗传学病理学和治疗
- 批准号:
10630937 - 财政年份:2015
- 资助金额:
$ 59.4万 - 项目类别:
Epigenetic pathology and therapy in Huntington's disease
亨廷顿病的表观遗传学病理学和治疗
- 批准号:
9121773 - 财政年份:2015
- 资助金额:
$ 59.4万 - 项目类别:
相似国自然基金
抗β2糖基化磷脂结合蛋白I抗体参与高同型半胱氨酸血症协同高脂血症导致内皮细胞损伤及动脉粥样硬化的新机制
- 批准号:92168114
- 批准年份:2021
- 资助金额:53 万元
- 项目类别:面上项目
抗β2糖基化磷脂结合蛋白I抗体参与高同型半胱氨酸血症协同高脂血症导致内皮细胞损伤及动脉粥样硬化的新机制
- 批准号:82170452
- 批准年份:2021
- 资助金额:53.00 万元
- 项目类别:面上项目
基于病证结合的冠心病心力衰竭血瘀证演变规律及中医药干预机制研究
- 批准号:
- 批准年份:2020
- 资助金额:297 万元
- 项目类别:重点项目
基于动态关联网络分析策略的非创伤性股骨头坏死血瘀证病机演变规律及病证方结合研究
- 批准号:
- 批准年份:2020
- 资助金额:297 万元
- 项目类别:重点项目
青海血蜱唾液腺内凝血因子FⅡa/FXa结合蛋白的筛选鉴定
- 批准号:81760375
- 批准年份:2017
- 资助金额:33.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Contribution of Endothelial Planar Cell Polarity pathways in Blood Flow Direction Sensing
内皮平面细胞极性通路在血流方向传感中的贡献
- 批准号:
10750690 - 财政年份:2024
- 资助金额:
$ 59.4万 - 项目类别:
Molecular basis of glycan recognition by T and B cells
T 和 B 细胞识别聚糖的分子基础
- 批准号:
10549648 - 财政年份:2023
- 资助金额:
$ 59.4万 - 项目类别:
Endothelial Cell Reprogramming in Familial Intracranial Aneurysm
家族性颅内动脉瘤的内皮细胞重编程
- 批准号:
10595404 - 财政年份:2023
- 资助金额:
$ 59.4万 - 项目类别:
Molecular mechanisms regulating LMO2+ metastasis initiating cells
调节LMO2转移起始细胞的分子机制
- 批准号:
10659840 - 财政年份:2023
- 资助金额:
$ 59.4万 - 项目类别:
Cellular and Metabolic Dysfunction in Sepsis-Induced Immune Paralysis
脓毒症引起的免疫麻痹中的细胞和代谢功能障碍
- 批准号:
10724018 - 财政年份:2023
- 资助金额:
$ 59.4万 - 项目类别: